Compare AGIO & CLBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AGIO | CLBK |
|---|---|---|
| Founded | 2007 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.2B |
| IPO Year | 2013 | 2026 |
| Metric | AGIO | CLBK |
|---|---|---|
| Price | $37.57 | $10.85 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 1 |
| Target Price | ★ $38.88 | $17.00 |
| AVG Volume (30 Days) | 1.0M | ★ 6.0M |
| Earning Date | 04-29-2026 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $43,011,000.00 | N/A |
| Revenue This Year | $76.75 | $3.97 |
| Revenue Next Year | $170.73 | $11.43 |
| P/E Ratio | ★ N/A | $83.69 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.24 | $10.70 |
| 52 Week High | $46.00 | $25.83 |
| Indicator | AGIO | CLBK |
|---|---|---|
| Relative Strength Index (RSI) | 52.01 | 21.05 |
| Support Level | $26.71 | N/A |
| Resistance Level | $44.01 | $16.53 |
| Average True Range (ATR) | 1.69 | 0.71 |
| MACD | -0.77 | -1.35 |
| Stochastic Oscillator | 27.89 | 0.89 |
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.
Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a customer service-focused institution. The company offers traditional financial services to businesses and consumers in its market areas. It attracts deposits from the general public and uses those funds to originate various loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans. The company also offers title insurance through its wholly owned subsidiary and provides a broad range of insurance products, including personal and business lines of insurance, mainly to customers and New Jersey residents.